Skip to main content
CVS HEALTH Corp logo

CVS HEALTH Corp — Investor Relations & Filings

Ticker · CVS ISIN · US1266501006 LEI · 549300EJG376EN5NQE29 US Human health and social work activities
Open in API
Filings indexed 2,766 across all filing types
Latest filing 2023-05-02 Regulatory Filings
Country US United States of America
Listing US CVS

About CVS HEALTH Corp

https://cvshealth.com/

CVS Health Corporation is a diversified health solutions company that provides integrated healthcare services. The company operates through three main segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness. The Health Care Benefits segment offers a broad range of health insurance products and related services. The Health Services segment provides comprehensive pharmacy benefit management (PBM) solutions, specialty pharmacy services for complex conditions, and accessible clinical care through its network of retail health clinics and primary care centers. The Pharmacy & Consumer Wellness segment consists of its retail pharmacy chain, which dispenses prescription medications and sells a wide variety of over-the-counter health products, personal care items, and general merchandise. The company focuses on simplifying the healthcare experience and improving health outcomes by making care more accessible, affordable, and personalized.

Recent filings

Filing Released Lang Actions
REGISTRATION STATEMENT
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC. It relates to the registration of securities under the Securities Act of 1933, specifically concerning shares issuable under an Omnibus Incentive Plan following a merger. The document includes legal and regulatory disclosures, indemnification clauses, and references to other filings such as the 10-K and 8-K, but it is not itself a financial report or earnings release. It is a registration statement for securities issuance, which falls under the category of Regulatory Filings (RNS) as it does not fit into other specific categories like Annual Report, Earnings Release, or Capital/Financing Update. The document length is substantial and contains detailed legal and regulatory information typical of a registration statement.
2023-05-02 English
CURRENT REPORT
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC by CVS Health Corporation. It reports a material definitive agreement (a $5 billion term loan agreement) entered into in connection with a merger acquisition of Oak Street Health. The document includes detailed descriptions of the loan terms, the merger completion, and related financial obligations. It also references exhibits such as the Term Loan Agreement and a press release. The Form 8-K is a current report used to disclose significant events or corporate changes promptly, not a full annual or quarterly financial report. It is not an earnings release, proxy statement, or management discussion. The document is lengthy (15,000 characters) and contains substantive information about financing and merger completion. Therefore, the best classification is Capital/Financing Update (CAP), as it primarily updates on financing activities related to the merger.
2023-05-02 English
Proxy Solicitation & Information Statement 2023
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Notice of Exempt Solicitation related to a stockholder proposal for CVS Health Corporation's annual meeting. It discusses a shareholder proposal requesting a report on worker rights assessment and urges shareholders to vote on this item. The document is not a financial report, earnings release, or management discussion. It is a solicitation communication related to proxy voting, which fits the category of Proxy Solicitation & Information Statement (PSI). The document length (6274 characters) and content confirm it is a solicitation notice rather than a full report or announcement of a report publication.
2023-04-26 English
ARS
Annual Report
2023-04-07 English
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
Remuneration Information Classification · 100% confidence The document is titled 'DEFA14A' and is described as 'Definitive Additional Proxy Soliciting Materials' filed with the SEC. It includes detailed information about the upcoming Annual Meeting of Stockholders, voting items, board recommendations, and instructions for voting. The presence of proxy solicitation materials and voting proposals indicates this is related to proxy solicitation and executive compensation voting. The form DEFA14A is specifically used for definitive additional proxy solicitation materials, which falls under Remuneration Information filings as it includes executive compensation proposals and related voting information. Therefore, the document is best classified as Remuneration Information (DEF 14A). The document length is 4615 characters, which is consistent with a detailed proxy solicitation material rather than a brief announcement or a full annual report.
2023-04-07 English
DEFINITIVE PROXY STATEMENT
Proxy Solicitation & Information Statement
2023-04-07 English

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.